Drug profile · INN
vestronidase alfa-vjbk
MEPSEVII
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
vestronidase alfa-vjbk (MEPSEVII) is an FDA-listed pharmaceutical active ingredient. Associated with Ultragenyx UK Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN vestronidase alfa-vjbk
Brand MEPSEVII
Route INJECTION
Formulation INJECTABLE
Originator Ultragenyx UK Limited
Frequently asked questions
What is vestronidase alfa-vjbk?
vestronidase alfa-vjbk (MEPSEVII) is an FDA-listed pharmaceutical active ingredient. Associated with Ultragenyx UK Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for vestronidase alfa-vjbk?
MEPSEVII is a marketed brand name for vestronidase alfa-vjbk. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vestronidase alfa-vjbk?
vestronidase alfa-vjbk has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.